Zhengye Biotechnology Holding L

2.1800-0.14 (-6.03%)
Oct 28, 4:00:01 PM EDT · NasdaqCM · ZYBT · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
103.31M
P/E (TTM)
72.67
Basic EPS (TTM)
0.03
Dividend Yield
0%

About

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

CEO
Mr. Songlin Song
IPO
1/7/2025
Employees
277
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic